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Neonatal treatment of female mice with diethylstilbestrol (DES) is known to induce ovary-independent persistent proliferation and cornification of
vaginal epithelium. This irreversibly changed vaginal epithelium persistently expressed higher levels of c-jun and c-fos mRNAs, which was not altered
by postpubertal estrogen. Sexual dimorphism was encountered in mouse pelvis and anococcygeus muscle. Postpubertal estrogen changed the
shape of the pelvis to the female type and postpubertal androgen changed it to the male type. Neonatal exposure to DES and to the antiestrogen
tamoxifen altered the developmental pattern of the pelvis, which contained lower concentrations of calcium and phosphorus than controls. The size
of anococcygeus muscle was increased by postpubertal androgen but decreased by postpubertal estrogen. However, neonatal estrogen (DES)
exposure permanently enlarged the anococcygeus muscle. Thus, neonatal treatment of mice with estrogen and antiestrogen results in irreversible
changes in nonreproductive as well as reproductive structures. - Environ Health Perspect 103(Suppl 7):79-82 (1995)
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Introduction
The study of permanent changes in target
organs induced by sex hormones adminis-
tered during a critical period of develop-
ment began with experiments on the
neonatal mouse treated with estrogens
(1-4). The vaginal epithelium of mice
treated neonatally with estrogen, including
diethylstilbestrol (DES), showed persistent
proliferation and cornification, frequently
resulting in precancerous and cancerous
lesions (5). Perinatally sex hormone-
exposed female rodents show lesions in
vagina and cervix, uterine metaplasia and
tumors, oviducal malformations and
tumors, polyovular follicles in the ovary,
and mammary gland hyperplasia, dysplasia,
and neoplasia (6-12). Perinatal treatment
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ofmale mice with estrogenic hormones gives
rise to neoplastic changes in coagulating
gland, seminal vesicle, and testis (13,14).
Nongenital abnormalities have also been
reported in mice exposed perinatally to sex
hormones and antihormones (12,15-18).
This paper describes briefly some genital and
nongenital abnormalities found in mice
exposed neonatally to the estrogen DES and
to the antiestrogen tamoxifen.
Protooncogene Expression in
Vagina and Uterus of Mice
Exposed Neonatallyto DES
Estrogens stimulate DNA synthesis and
cell proliferation in the female reproductive
tract (19) by initially binding to high-
affinity nuclear estrogen receptors that
directly regulate transcription of target
genes by binding to DNA estrogen-respon-
sive elements (20). Products of the genes
activated through the estrogen receptor
play a role in amplifying the tissue
response. As a primary response to the
estrogen receptor complex, c-fos, c-jun and
c-myc protooncogenes are expressed in
immature and adult rat uterus (21) and
mouse vagina (22).
The direct effect of estrogen on the
expression of these protooncogenes was
examined by Northern blot analysis of
vagina and uterus in 50-day-old ovariec-
tomized mice exposed neonatally to DES.
In ovariectomized, unexposed control
mice, the expression of c-jun and c-fos
mRNAs in the uterus was stimulated by
17,-estradiol. Within 1 hr after estradiol
administration at 50 days, c-jun and c-fos
mRNAs increased in concentration, show-
ing a peak 3 hr after estradiol stimulation
and decreasing with time thereafter. In the
vagina, the concentration ofc-jun and c-fos
mRNAs increased rapidly, reaching a peak
within 1 hr. The expression of c-myc in
uterus and vagina was not changed by
postpubertal estrogen. Expressions ofc-jun
and c-fos mRNAs were greater in both the
uterus (3- and 6-fold, respectively) and the
vagina (18- and 4-fold) ofneonatally DES-
exposed mice than in control organs. These
increased levels of c-jun and c-fos expres-
sion were not further altered by postpuber-
tal estradiol and may be related to
ovary-independent persistent changes in
the genital tract.
Mouse Pelvis: Sexual
Dimorphism and
Responsiveness
Hormones
to Steroid
The mouse pelvis is sexually dimorphic (23,
24). A pair of innominate bones, the ossa
coxae, are composed offour separate units:
ilium, ischium, pubis, and acetabulum,
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which unite at the ventral midline as the
pubic symphysis to form the pelvis. The
innominate bone is connected dorsomedi-
ally with the sacrum by the iiosacral joint.
Gardner (23) reported that there is no dif-
ference in the shape ofthe innominate bone
in young male and female mice; however,
after sexual maturity, the pubic bone in
females is thinner than in males. Long-term
administration of estrogenic hormones to
male mice induces a female-type pelvis with
thin pubic bones, indicating that sex hor-
mones play a role in pelvic morphogenesis.
Sexual dimorphism of the innominate
bone was found in adult T-strain rats and
Chinese hamsters, as well as in mice, by
computer-aided morphometric analysis
(25). Sexual differences in the pubis and
the ischium appeared in mice at 30 and
120 days ofage, respectively (24,26). The
pubis in female mice was longer and thin-
ner than in males, and the ischium in male
mice was shorter and thicker than in
females in 14 strains of mice. Serum
androgen levels in male mice increased
from 30 to 50 days ofage (27), suggesting
that in male mice the shape of pelvic
bones is determined by postpubertally
secreted androgens.
The ratio of the width of the ischium
to the longitudinal length of the innomi-
nate bone in 120-day-old female mice was
significantly lower than in 30-day-old
females; thus ovarian estrogen secreted
postpubertally may participate in the for-
mation of the female pelvic bones. In
both male and female newborn mice,
estrogen receptors were immunohisto-
chemically detected in mesenchymal cells
surrounding pubis and ischium and in the
periosteum and osteocytes of pubis and
ischium, but not in the innominate bone.
A weak reaction for the receptors was also
observed in the chondrocytes ofpubis and
ischium (26).
The innominate bones from male mice
castrated on the day of birth and from
female mice given daily injections of20 pg
testosterone and 5a-dihydrotestosterone
for 5 days starting on the day ofbirth were
examined at 30 days of age. The ratio of
the pubis width to innominate length in
neonatally androgen-treated females at 30
days was greater than in the age-matched
untreated females, whereas this ratio was
smaller in neonatally castrated 30-day-old
males than in age-matched intact males. In
adult testicular-feminized male mice lack-
ing androgen receptors, ischium length and
width were significantly smaller than in the
wild-type males. Pubis width in testicu-
lar-feminized male mice was intermediate
between those of wild-type males and
females. The ischium in females and cas-
trated males was shorter and thinner than
in the males. The pubis in gonadec-
tomized males and females was wider than
in intact females and smaller than in intact
males. The pubis in intact males and cas-
trated males was shorter than in intact
females (26).
In summary, the basic type of ischium
is the female type; postnatal endogenous
androgen modifies the ischium to the male
phenotype, and the pubis phenotype is
intermediate between males and females;
postnatal endogenous androgen induces
the male type, and postpubertal endoge-
nous estrogen induces the female type.
These results suggest that the shape of the
innominate bone is transformed to the
male type under the influence ofearly post-
natal androgen (12,26).
Neonatal tamoxifen treatment caused a
long-lasting inhibition of pubic bone
calcification; the elastic and cartilaginous
nature of the symphysis region continued
into adulthood. Neonatally tamoxifen-
exposed mice showed hernia ofthe urinary
bladder with or without descent ofthe cae-
cum through the subpubic space (15,16).
Although the mechanism of the bladder
hernia is unknown, it may be related to the
modified symphysis pubis. Mice treated
with tamoxifen for 5 days starting at 0 to
10 days of age had significantly longer
pubic ligaments than did the correspond-
ing controls. However, mice treated neona-
tally with clomiphene and nafoxidine
possessed normal pubic bones (16).
In 120-day-old female mice treated
neonatally with 100 pg tamoxifen, the total
area of the pelvis and the individual areas
of the ilium, ischium, and pubis were
significantly smaller than in the controls.
There was no significant difference in the
length of ischium between tamoxifen-
treated and control mice of both sexes.
However, lengths of ilium and pubis and
widths of ilium, pubis, and ischium in
tamoxifen-treated male and female mice
were significantly smaller than in the
respective controls. In contrast, neonatal
treatment with 2 pg DES for 5 days from
the day ofbirth did not affect the shape of
the pelvis ofeither sex (24).
Indicators of bone resorption in the
endosteal area ofthe pubic bone were mea-
sured on histological sections. The number
of active osteoclasts was counted per unit
area of bone section. In 15-day-old mice
given neonatal injections oftamoxifen, the
osteoclastic surface, the number of osteo-
clasts per unit area, and the number of
nuclei per osteoclast were significantly
smaller than in the controls. Inhibition of
ossification persisted in the junction of
pubis and ischium of pelvis transplanted
under the kidney capsule after treatment
with tamoxifen in vitro (18).
These findings indicate that neonatally
injected tamoxifen mainly retards the
growth of the ilium and pubis in mice by
changing the activities of osteoclasts and
osteoblasts and that tamoxifen acts directly
on the neonatal mouse pubis as an anti-
estrogen to inhibit its ossification.
Neonatally DES-treated female mice
showed lower amounts of calcium and
phosphorus in pelvis and femur at 12
months ofage but not at 2 months ofage.
The pelvises of 3- to 15-month-old male
mice treated neonatally with DES and
tamoxifen had lower amounts of calcium
and phosphorus than age-matched controls
(Figure 1). The femurs of3- to 15-month-
old male mice treated neonatally with
tamoxifen, but not with DES, had lower
amounts of calcium and phosphorus than
age-matched controls (Figure 1). These
results indicate that neonatal DES and
tamoxifen exposure can result in perma-
nent changes in bone tissue in older male
and female mice (17).
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Figure 1. Total amount of calcium per mm length of
pelvis (A) and femur (B) in control, DES-, and tamox-
ifen (Tx)-treated male mice.
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Mouse Anococcygeus Muscle:
Sexual Dimorphism and
Responsiveness to Steroid
Hormones
The anococcygeus muscle described in rats
by Gillespie (28) is a paired, thin sheet of
smooth muscle inserting on the rectum,
having a tendinous origin largely on sacral
vertebrae (28,29). A dense adrenergic
innervation is distributed through the mus-
cle along with peptidergic innervation but
apparently no cholinergic innervation
(30). The physiological role ofthe muscle,
however, has not yet been explained.
The rat levator ani muscle from the per-
ineal muscle complex shows sexual dimor-
phism and its growth is controlled by
testosterone (31). The rat costo-uterine
muscle, which provides a skeletal attach-
ment for the longitudinal myometrial layer
ofthe uterine horn, is also responsive to sex
steroids (32). The length ofthe muscle cell
increases during pregnancy and after estro-
gen treatment. However, possible sexual
dimorphism and the effect of sex steroids
on growth ofthe anococcygeus muscle have
not yet been studied, although it has been
reported that the muscle in male rat is bigger
than in the female (33). The mouse anoc-
cocygeus muscle was examined for sexual
dimorphism, responsiveness to neonatal and
postnatal sex hormones including DES, and
androgen and estrogen receptor expression.
Cross-sections of the anococcygeus
muscle of C57BL, ICR and BALB/c mice
at 90 days ofage showed histology charac-
teristic of smooth muscle. Sexual dimor-
phism of the muscle was demonstrated in
the three mouse strains: the cross-sectional
area of the muscle in male mice was
significantly larger (1.6 - 3.3 times) than
that of females (34). Castration signifi-
cantly reduced the muscle area in male
mice. Implantation of a pellet of testos-
terone increased the muscle area of cas-
trated males. Ovariectomy at 30 days of
age increased the muscle area at 60 days of
age, but an implantation of estradiol in
ovariectomized mice further reduced the
muscle area. Estrogen also reduced the
muscle area in male mice. Both androgen
receptors and estrogen receptors were
expressed in the muscle cells until 60 days
ofage in both sexes.
Neonatal exposure to DES significantly
reduced the anococcygeus muscle area in
60-day-old male mice, but strikingly
increased (3.1 times) the muscle area in
age-matched females. These opposite
effects ofDES on male and female muscles
are surprising. Serum androgen levels in
neonatally DES-exposed male mice were
not different from those in controls
(Fukazawa and Iguchi, unpublished data).
The decrease in muscle area seen in neona-
tally DES-exposed male mice at 60 days of
age was not evident if mice were castrated
at 30 days of age. The muscle area of
neonatally DES-exposed female mice was
significantly larger than in controls, and
ovariectomy at 30 days ofage did not alter
this, indicating that the increase in the area
by neonatal DES exposure had occurred
before 30 days ofage and was not affected
by later ovarian hormone withdrawal.
These results suggest that both androgen
and estrogen play an important role in
induction ofsexual dimorphism ofanococ-
cygeus muscle: the muscle is under the
control of both androgen and estrogen
during the pubertal period, and estrogen
(DES) has an irreversible stimulatory effect
on the muscle in neonatal female mice.
Conclusions
The study of animals treated perinatally
with sex hormones and related compounds
provides an opportunity to analyze various
factors influencing developmental and car-
cinogenic processes (8-12). Thus, the pre-
natal and neonatal mouse models continue
to indicate possible genital and nongenital
changes in human offspring exposed dur-
ing development to estrogenic hormones,
antihormones, and xenobiotics. In further
studies, more attention should be paid to
abnormalities in nongenital organs exposed
to various estrogenic agents during fetal
and early postnatal development in
mammals including humans.
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